Estimating the value of avoiding morbidity and mortality from foodborne illnesses.

When people consume products violating the Food, Drug, and Cosmetic (FD&C) Act they may experience morbidity or mortality from foodborne illness. Some studies have used survey data to estimate the dollar value of avoiding a few illnesses, but surveys are expensive and the resulting estimates cannot easily be generalized to the wide variety of foodborne illnesses. We develop a method that uses published data to estimate the value of avoiding morbidity and mortality from foodborne illnesses using two metrics--quality-adjusted life-years and dollars. The method first describes the effects of different illnesses on the patient and then converts these descriptions into changes in time spent in different health states with different relative utility weights. We use these estimated changes to compute losses in quality-adjusted life-years. We demonstrate our method and derive estimates for the value of avoiding a future case of botulism, salmonellosis, chronic hepatitis, and bladder cancer. Researchers can use our method to compare the value of avoiding all illnesses caused by violations of the FD&C Act. More importantly, government officials can use our method to quickly and cost-effectively generate morbidity and mortality valuation estimates for any illness for policy purposes.

[1]  Mark C. Berger,et al.  Valuing Changes in Health Risks: A Comparison of Alternative Measures , 1987 .

[2]  J. Mann,et al.  Economic impact of a botulism outbreak. Importance of the legal component in food-borne disease. , 1983, JAMA.

[3]  E. Todd Economic Loss from Foodborne Disease Outbreaks Associated with Foodservice Establishments. , 1985, Journal of food protection.

[4]  M S Thompson,et al.  Willingness to pay and accept risks to cure chronic disease. , 1986, American journal of public health.

[5]  D. Archer,et al.  Incidence and Cost of Foodborne Diarrheal Disease in the United States. , 1985, Journal of food protection.

[6]  G. Torrance Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[7]  Comparing Expressed and Revealed Preferences for Risk Reduction: Different Hazards and Question Frames , 1988 .

[8]  P. Kind,et al.  A scale of valuations of states of illness: is there a social consensus? , 1978, International journal of epidemiology.

[9]  E. Todd Economic Loss from Foodborne Disease and Non-Illness Related Recalls Because of Mishandling by Food Processors. , 1985, Journal of food protection.

[10]  J. Morris,et al.  Botulism in the United States, 1979 , 1980 .

[11]  Richard J. Zeckhauser,et al.  Where Now for Saving Lives , 1976 .

[12]  Michael J. Moore,et al.  Doubling the Estimated Value of Life: Results Using New Occupational Fatality Data , 1988 .

[13]  Daniel M. Violette,et al.  The value of reducing risks of death: A note on new evidence , 1989 .

[14]  Sanford V. Berg,et al.  Distributional analysis of regional benefits and cost of air quality control , 1979 .

[15]  Michael J. Moore,et al.  The Quantity-Adjusted Value of Life , 1988 .